严重哮喘-话题@MedSci

#严重哮喘#

16篇内容 | 1189人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1717848, encodeId=caea1e1784855, content=<a href='/topic/show?id=e40c2116554' target=_blank style='color:#2F92EE;'>#严重哮喘#</a>, objectTitle=NEJM：白细胞介素-23 Risankizumab治疗严重哮喘II期临床失败, objectType=article, longId=219618, objectId=26792196183f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26792196183f, replyNumber=0, likeNumber=82, createdTime=2022-09-21, rootId=0, userName=lujian, userId=c4b932466782, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26792196183f, moduleTitle=NEJM：白细胞介素-23 Risankizumab治疗严重哮喘II期临床失败, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26792196183f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717846, encodeId=b2d81e1784678, content=<a href='/topic/show?id=e40c2116554' target=_blank style='color:#2F92EE;'>#严重哮喘#</a>, objectTitle=赛诺菲的IL-4/IL-13单抗Dupixent显著减轻儿童的严重哮喘发作, objectType=article, longId=202084, objectId=58c820208475, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58c820208475, replyNumber=0, likeNumber=85, createdTime=2021-09-04, rootId=0, userName=lujian, userId=c4b932466782, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58c820208475, moduleTitle=赛诺菲的IL-4/IL-13单抗Dupixent显著减轻儿童的严重哮喘发作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58c820208475)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717847, encodeId=22d61e17847a2, content=<a href='/topic/show?id=e40c2116554' target=_blank style='color:#2F92EE;'>#严重哮喘#</a>, objectTitle=阿斯利康的TSLP单抗tezepelumab治疗严重哮喘，III期临床成功, objectType=article, longId=203246, objectId=d0c62032469d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0c62032469d, replyNumber=0, likeNumber=67, createdTime=2021-06-07, rootId=0, userName=lujian, userId=c4b932466782, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0c62032469d, moduleTitle=阿斯利康的TSLP单抗tezepelumab治疗严重哮喘，III期临床成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0c62032469d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717845, encodeId=0c5b1e1784599, content=<a href='/topic/show?id=e40c2116554' target=_blank style='color:#2F92EE;'>#严重哮喘#</a>, objectTitle=Am J Respir Crit Care Med：严重哮喘患者的辣椒素敏感性增加与临床结果恶化相关, objectType=article, longId=188462, objectId=09661884621d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09661884621d, replyNumber=0, likeNumber=60, createdTime=2020-10-12, rootId=0, userName=lujian, userId=c4b932466782, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09661884621d, moduleTitle=Am J Respir Crit Care Med：严重哮喘患者的辣椒素敏感性增加与临床结果恶化相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=09661884621d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717844, encodeId=582a1e17844cd, content=<a href='/topic/show?id=e40c2116554' target=_blank style='color:#2F92EE;'>#严重哮喘#</a>, objectTitle=Chiesi Group宣布其单吸入器三联疗法治疗严重哮喘的两项III期阳性数据, objectType=article, longId=181536, objectId=e56f1815365e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e56f1815365e, replyNumber=0, likeNumber=75, createdTime=2020-08-18, rootId=0, userName=lujian, userId=c4b932466782, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e56f1815365e, moduleTitle=Chiesi Group宣布其单吸入器三联疗法治疗严重哮喘的两项III期阳性数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e56f1815365e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717843, encodeId=34e91e1784339, content=<a href='/topic/show?id=e40c2116554' target=_blank style='color:#2F92EE;'>#严重哮喘#</a>, objectTitle=2019 法国指南：严重哮喘发作的管理, objectType=article, longId=181238, objectId=e52818123857, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e52818123857, replyNumber=0, likeNumber=54, createdTime=2020-04-21, rootId=0, userName=lujian, userId=c4b932466782, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e52818123857, moduleTitle=2019 法国指南：严重哮喘发作的管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e52818123857)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717842, encodeId=5cf21e178423c, content=<a href='/topic/show?id=e40c2116554' target=_blank style='color:#2F92EE;'>#严重哮喘#</a>, objectTitle=2019 GINA指南：成人和青少年难治性严重哮喘的诊断和管理（袖珍版）, objectType=article, longId=165456, objectId=1fe116545693, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fe116545693, replyNumber=0, likeNumber=45, createdTime=2019-05-21, rootId=0, userName=lujian, userId=c4b932466782, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fe116545693, moduleTitle=2019 GINA指南：成人和青少年难治性严重哮喘的诊断和管理（袖珍版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1fe116545693)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717841, encodeId=aeb91e1784162, content=<a href='/topic/show?id=e40c2116554' target=_blank style='color:#2F92EE;'>#严重哮喘#</a>, objectTitle=J Aller Cl Imm-Pract：病毒引起的严重哮喘急性发作成年患者血清IgG浓度的意义, objectType=article, longId=158121, objectId=58ef158121ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58ef158121ca, replyNumber=0, likeNumber=82, createdTime=2019-05-23, rootId=0, userName=lujian, userId=c4b932466782, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58ef158121ca, moduleTitle=J Aller Cl Imm-Pract：病毒引起的严重哮喘急性发作成年患者血清IgG浓度的意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58ef158121ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717840, encodeId=ffa41e178404b, content=<a href='/topic/show?id=e40c2116554' target=_blank style='color:#2F92EE;'>#严重哮喘#</a>, objectTitle=BORA III期延展试验证明阿斯利康IL-5单抗Fasenra对严重哮喘具有长期疗效, objectType=article, longId=149082, objectId=636f14908287, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=636f14908287, replyNumber=0, likeNumber=66, createdTime=2018-12-01, rootId=0, userName=lujian, userId=c4b932466782, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=636f14908287, moduleTitle=BORA III期延展试验证明阿斯利康IL-5单抗Fasenra对严重哮喘具有长期疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=636f14908287)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717839, encodeId=96981e17839e2, content=<a href='/topic/show?id=e40c2116554' target=_blank style='color:#2F92EE;'>#严重哮喘#</a>, objectTitle=2018 专家更佳实践建议：支气管热成型术治疗严重哮喘, objectType=article, longId=136123, objectId=8b27136123a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b27136123a5, replyNumber=0, likeNumber=45, createdTime=2018-09-10, rootId=0, userName=lujian, userId=c4b932466782, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b27136123a5, moduleTitle=2018 专家更佳实践建议：支气管热成型术治疗严重哮喘, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b27136123a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717838, encodeId=339a1e1783879, content=<a href='/topic/show?id=e40c2116554' target=_blank style='color:#2F92EE;'>#严重哮喘#</a>, objectTitle=NEJM：4倍量增加糖皮质激素吸入用于严重哮喘恶化的临时预防, objectType=article, longId=131700, objectId=4d5c131e00a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d5c131e00a5, replyNumber=0, likeNumber=59, createdTime=2018-10-06, rootId=0, userName=lujian, userId=c4b932466782, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d5c131e00a5, moduleTitle=NEJM：4倍量增加糖皮质激素吸入用于严重哮喘恶化的临时预防, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d5c131e00a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717835, encodeId=7e2a1e17835ea, content=<a href='/topic/show?id=e40c2116554' target=_blank style='color:#2F92EE;'>#严重哮喘#</a>, objectTitle=欧盟批准AZ的Fasenra治疗严重哮喘, objectType=article, longId=126316, objectId=730b1263163a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=730b1263163a, replyNumber=0, likeNumber=81, createdTime=2018-04-21, rootId=0, userName=lujian, userId=c4b932466782, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=730b1263163a, moduleTitle=欧盟批准AZ的Fasenra治疗严重哮喘, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=730b1263163a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717836, encodeId=166a1e17836ba, content=<a href='/topic/show?id=e40c2116554' target=_blank style='color:#2F92EE;'>#严重哮喘#</a>, objectTitle=Eur Respir J：鉴别儿童严重哮喘新工具：吸入性糖皮质激素依从性电子监测, objectType=article, longId=126959, objectId=ce5012695982, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce5012695982, replyNumber=0, likeNumber=60, createdTime=2018-10-23, rootId=0, userName=lujian, userId=c4b932466782, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce5012695982, moduleTitle=Eur Respir J：鉴别儿童严重哮喘新工具：吸入性糖皮质激素依从性电子监测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce5012695982)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717837, encodeId=184a1e17837e4, content=<a href='/topic/show?id=e40c2116554' target=_blank style='color:#2F92EE;'>#严重哮喘#</a>, objectTitle=赛诺菲将Dupixent用于严重哮喘, objectType=article, longId=131488, objectId=ea3e13148802, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea3e13148802, replyNumber=0, likeNumber=68, createdTime=2018-08-12, rootId=0, userName=lujian, userId=c4b932466782, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea3e13148802, moduleTitle=赛诺菲将Dupixent用于严重哮喘, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea3e13148802)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717834, encodeId=d1fb1e1783443, content=<a href='/topic/show?id=e40c2116554' target=_blank style='color:#2F92EE;'>#严重哮喘#</a>, objectTitle=Cochrane Database Syst Rev：补充维生素D可减少严重哮喘的发作, objectType=article, longId=76836, objectId=5dace683615, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5dace683615, replyNumber=0, likeNumber=76, createdTime=2017-05-21, rootId=0, userName=lujian, userId=c4b932466782, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5dace683615, moduleTitle=Cochrane Database Syst Rev：补充维生素D可减少严重哮喘的发作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5dace683615)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717833, encodeId=965c1e1783355, content=<a href='/topic/show?id=e40c2116554' target=_blank style='color:#2F92EE;'>#严重哮喘#</a>, objectTitle=NEJM：氟替卡松+沙美特罗VS氟替卡松的严重哮喘事件, objectType=article, longId=64438, objectId=5f7c6443850, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f7c6443850, replyNumber=0, likeNumber=100, createdTime=2016-07-26, rootId=0, userName=lujian, userId=c4b932466782, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f7c6443850, moduleTitle=NEJM：氟替卡松+沙美特罗VS氟替卡松的严重哮喘事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f7c6443850)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

严重哮喘

2020-05-29

lujian (审核中...)

前往app查看评论内容

#严重哮喘#

NEJM：白细胞介素-23 Risankizumab治疗严重哮喘II期临床失败

2022-09-21

lujian (审核中...)

前往app查看评论内容

#严重哮喘#

赛诺菲的IL-4/IL-13单抗Dupixent显著减轻儿童的严重哮喘发作

2021-09-04

lujian (审核中...)

前往app查看评论内容

#严重哮喘#

阿斯利康的TSLP单抗tezepelumab治疗严重哮喘，III期临床成功

2021-06-07

lujian (审核中...)

前往app查看评论内容

#严重哮喘#

Am J Respir Crit Care Med：严重哮喘患者的辣椒素敏感性增加与临床结果恶化相关

2020-10-12

lujian (审核中...)

前往app查看评论内容

#严重哮喘#

Chiesi Group宣布其单吸入器三联疗法治疗严重哮喘的两项III期阳性数据

2020-08-18

lujian (审核中...)

前往app查看评论内容

#严重哮喘#

2019 法国指南：严重哮喘发作的管理

2020-04-21

lujian (审核中...)

前往app查看评论内容

#严重哮喘#

2019 GINA指南：成人和青少年难治性严重哮喘的诊断和管理（袖珍版）

2019-05-21

lujian (审核中...)

前往app查看评论内容

#严重哮喘#

J Aller Cl Imm-Pract：病毒引起的严重哮喘急性发作成年患者血清IgG浓度的意义

2019-05-23

lujian (审核中...)

前往app查看评论内容

#严重哮喘#

BORA III期延展试验证明阿斯利康IL-5单抗Fasenra对严重哮喘具有长期疗效

2018-12-01

lujian (审核中...)

前往app查看评论内容

#严重哮喘#

2018 专家更佳实践建议：支气管热成型术治疗严重哮喘

2018-09-10

lujian (审核中...)

前往app查看评论内容

#严重哮喘#

NEJM：4倍量增加糖皮质激素吸入用于严重哮喘恶化的临时预防

2018-10-06

lujian (审核中...)

前往app查看评论内容

#严重哮喘#

欧盟批准AZ的Fasenra治疗严重哮喘

2018-04-21

lujian (审核中...)

前往app查看评论内容

#严重哮喘#

Eur Respir J：鉴别儿童严重哮喘新工具：吸入性糖皮质激素依从性电子监测

2018-10-23

lujian (审核中...)

前往app查看评论内容

#严重哮喘#

赛诺菲将Dupixent用于严重哮喘

2018-08-12

lujian (审核中...)

前往app查看评论内容

#严重哮喘#

Cochrane Database Syst Rev：补充维生素D可减少严重哮喘的发作

2017-05-21

lujian (审核中...)

前往app查看评论内容

#严重哮喘#

NEJM：氟替卡松+沙美特罗VS氟替卡松的严重哮喘事件

2016-07-26

科室
- - 订阅+
  - 更多科室
工具
服务